Analysis of factors in successful nasal endoscopic resection of nasopharyngeal angiofibroma
- PMID: 26492972
- DOI: 10.3109/00016489.2015.1099734
Analysis of factors in successful nasal endoscopic resection of nasopharyngeal angiofibroma
Abstract
Conclusions: Endoscopic resection of nasopharyngeal angiofibroma is less traumatic, causes less bleeding, and provides a good curative effect. Using pre-operative embolization and controlled hypotension, reasonable surgical strategies and techniques lead to successful resection tumors of a maximum Andrews-Fisch classification stage of III.
Objective: To investigate surgical indications, methods, surgical technique, and curative effects of transnasal endoscopic resection of nasopharyngeal angiofibroma, this study evaluated factors that improve diagnosis and treatment, prevent large intra-operative blood loss and residual tumor, and increase the cure rate.
Methods: A retrospective analysis was performed of the clinical data and treatment programs of 23 patients with nasopharyngeal angiofibroma who underwent endoscopic resection with pre-operative embolization and controlled hypotension. The surgical method applied was based on the size of tumor and extent of invasion. Curative effects were observed.
Results: No intra-operative or perioperative complications were observed in 22 patients. Upon removal of nasal packing material 3-7 days post-operatively, one patient experienced heavy bleeding of the nasopharyngeal wound, which was treated compression hemostasis using post-nasal packing. Twenty-three patients were followed up for 6-60 months. Twenty-two patients experienced cure; one patient experienced recurrence 10 months post-operatively, and repeat nasal endoscopic surgery was performed and resulted in cure.
Keywords: Nasal endoscopy; prognosis; surgery; treatment.
Similar articles
-
Coblation-assisted endonasal endoscopic resection of juvenile nasopharyngeal angiofibroma.J Laryngol Otol. 2011 Sep;125(9):940-4. doi: 10.1017/S0022215111001344. Epub 2011 Jun 8. J Laryngol Otol. 2011. PMID: 21729442
-
Stage III nasopharyngeal angiofibroma: Improving results with endoscopic-assisted midfacial degloving and modification to the Fisch staging system.J Craniomaxillofac Surg. 2015 Oct;43(8):1678-83. doi: 10.1016/j.jcms.2015.07.025. Epub 2015 Jul 31. J Craniomaxillofac Surg. 2015. PMID: 26302935
-
Exclusively endoscopic surgery for juvenile nasopharyngeal angiofibroma.Otolaryngol Head Neck Surg. 2007 Sep;137(3):492-6. doi: 10.1016/j.otohns.2007.03.003. Otolaryngol Head Neck Surg. 2007. PMID: 17765782
-
Endoscopic surgery for juvenile nasopharyngeal angiofibroma: where are the limits?Curr Opin Otolaryngol Head Neck Surg. 2006 Feb;14(1):1-5. doi: 10.1097/01.moo.0000188859.91607.65. Curr Opin Otolaryngol Head Neck Surg. 2006. PMID: 16467630 Review.
-
Endoscopic resection of juvenile nasopharyngeal angiofibroma.Adv Otorhinolaryngol. 2012;73:132-6. doi: 10.1159/000334470. Epub 2012 Mar 29. Adv Otorhinolaryngol. 2012. PMID: 22472245 Review.
Cited by
-
Nasal septal angiofibroma: less vascular behaviour than observed in radiological imaging, a rare case in a 51-year-old woman.Ann R Coll Surg Engl. 2021 Feb;103(2):e48-e49. doi: 10.1308/rcsann.2020.7027. Ann R Coll Surg Engl. 2021. PMID: 33559557 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical